Therefore, the Medication Adherence in Saudi Arabia (MASA) Study is the first study in Saudi Arabia to assess adherence to OHAs among participants with Type 2 diabetes who are not using insulin and to use a comprehensive framework of theoretical underpinning to explore the factors associated with adherence behaviour. The gene discussed is INS; the disease is type 2 diabetes mellitus.